Home > Cashflow Statement > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Cashflow Statement

AD     Remove this Ad

ONESOURCE SPECIALTY PHARMA Last 5 Year Cashflow Statement History

[Standalone]

Mar2025Mar2024Mar2023
Profit Before Tax₹-22 Cr₹-390 Cr₹-799 Cr
Adjustment ₹285 Cr₹288 Cr₹605 Cr
Changes In working Capital ₹-303 Cr₹-6.66 Cr₹19 Cr
Cash Flow after changes in Working Capital ₹-40 Cr₹-109 Cr₹-176 Cr
Cash Flow from Operating Activities ₹-47 Cr₹-109 Cr₹-165 Cr
Cash Flow from Investing Activities ₹-300 Cr₹506 Cr₹-66 Cr
Cash Flow from Financing Activities ₹417 Cr₹-384 Cr₹118 Cr
Net Cash Inflow / Outflow ₹70 Cr₹13 Cr₹-112 Cr
Opening Cash & Cash Equivalents ₹22 Cr₹9.41 Cr₹121 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹92 Cr₹22 Cr₹9.41 Cr

Compare Cashflow Statement of peers of ONESOURCE SPECIALTY PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA ₹15,554.1 Cr -7.6% 2.5% -21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


ONESOURCE SPECIALTY PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ONESOURCE SPECIALTY PHARMA

-7.6%

2.5%

-21.4%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses